Menu

Studies Retracted After UCLA Investigation

Most of the authors have had papers pulled in the past.

Jul 21, 2017
Diana Kwon

PIXABAY, JACKMAC34A 2011 Cancer Research paper was retracted earlier this month (July 2) after an investigation by the University of California, Los Angeles (UCLA). The work was conducted by a group of cancer investigators at the university, including James Economou, the former vice chancellor for research.

According to the retraction report, the request came from UCLA, where an institutional review found that one of the paper’s figures duplicated aspects of another paper.

“This is the second retraction we’re aware of to come out of an investigation by UCLA’s Office of Research Policy and Compliance that has touched this group of scientists,” Retraction Watch reports. A 2012 Molecular Cancer Therapeutics paper coauthored by Economou was retracted in May.

This is the fourth retraction for one of the study’s coauthors, Benjamin Bonavida, a retired UCLA scientist. When asked about the most recent Cancer Research study, he tells Retraction Watch that “all the work was done in Economou’s lab, not mine. I have no idea what exactly took place.”

Only one of the coauthors of the Cancer Research paper has no previous retractions.

Retractions of scientific papers are on the rise. Just last year, more than 650 papers were pulled for various reasons, ranging from image duplication to fraud.

See “Infographic: Web of Retractions

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.